Fabio Lugoboni Selected Research

Opiate Substitution Treatment

1/2021	Impact of opioid-induced constipation on opioid substitution therapy management: the patient perspective.
1/2020	Association between Adult Attention Deficit/Hyperactivity Disorder and Intravenous Misuse of Opioid and Benzodiazepine in Patients under Opioid Maintenance Treatment: A Cross-Sectional Multicentre Study.
1/2017	Gender-related psychopathology in opioid use disorder: Results from a representative sample of Italian addiction services.
1/2017	Erectile dysfunction and quality of life in men receiving methadone or buprenorphine maintenance treatment. A cross-sectional multicentre study.
11/2016	High prevalence of constipation and reduced quality of life in opioid-dependent patients treated with opioid substitution treatments.
1/2012	Tobacco addiction and smoking status in heroin addicts under methadone vs. buprenorphine therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Fabio Lugoboni Research Topics

Disease

9	Substance-Related Disorders (Drug Abuse) 01/2021 - 08/2004
7	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 12/2021 - 01/2017
4	Gambling (Pathological Gambling) 01/2022 - 01/2018
4	Opioid-Related Disorders (Opiate Addiction) 01/2019 - 08/2006
4	Infections 01/2009 - 01/2002
3	Opioid-Induced Constipation 06/2022 - 12/2020
3	Cognitive Dysfunction 01/2021 - 01/2017
3	Hepatitis A (Hepatitis, Infectious) 01/2009 - 12/2004
3	Hepatitis B 01/2009 - 08/2002
2	Constipation 01/2021 - 11/2016
2	Alcoholism (Alcohol Abuse) 01/2021 - 09/2008
2	Pain (Aches) 12/2020 - 12/2019
2	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2020 - 12/2019
2	Sleep Wake Disorders 11/2019 - 08/2019
2	Seizures (Absence Seizure) 10/2017 - 02/2012
2	Erectile Dysfunction 01/2017 - 04/2008
2	Tobacco Use Disorder (Nicotine Dependence) 01/2012 - 04/2003
2	Syphilis 08/2006 - 01/2002
1	Urticaria (Hives) 01/2022
1	Neurobehavioral Manifestations 01/2021
1	COVID-19 01/2021
1	Bipolar Disorder (Manic Depressive Psychosis) 11/2019
1	Mental Disorders (Mental Disorder) 11/2019
1	Psychotic Disorders (Schizoaffective Disorder) 11/2019
1	Personality Disorders (Personality Disorder) 11/2019
1	Chemical and Drug Induced Liver Injury 05/2018
1	Parkinson Disease (Parkinson's Disease) 01/2018
1	Disruptive, Impulse Control, and Conduct Disorders (Kleptomania) 01/2018
1	Lethargy 08/2011
1	Paranoid Disorders (Paranoia) 08/2011
1	Wounds and Injuries (Trauma) 08/2011
1	Hallucinations (Hallucination) 08/2011
1	Liver Diseases (Liver Disease) 01/2011
1	Inflammation (Inflammations) 12/2009
1	Communicable Diseases (Infectious Diseases) 08/2006
1	Hepatitis 08/2006
1	Hepatitis C 04/2006
1	Cardiovascular Diseases (Cardiovascular Disease) 10/2005
1	Fever (Fevers) 12/2004
1	Tuberculosis (Tuberculoses) 01/2002

Drug/Important Bio-Agent (IBA)

16	BenzodiazepinesIBA 12/2021 - 01/2012
10	Heroin (Diamorphine)IBA 01/2020 - 01/2002
8	Pharmaceutical PreparationsIBA 01/2021 - 07/2003
7	Opioid Analgesics (Opioids)IBA 06/2022 - 11/2016
6	Methadone (Dolophine)FDA LinkGeneric 01/2017 - 04/2008
6	Buprenorphine (Subutex)FDA LinkGeneric 01/2017 - 04/2008
5	VaccinesIBA 01/2011 - 08/2002
2	Nicotine FDA Link 12/2021 - 04/2003
2	SolutionsIBA 01/2021 - 11/2019
2	Anticonvulsants (Antiepileptic Drugs)IBA 10/2017 - 02/2012
2	Illicit Drugs (Recreational Drugs)IBA 12/2004 - 01/2004
1	cytisineIBA 01/2022
1	Disulfiram (Antabuse)FDA Link 01/2021
1	etizolamIBA 01/2020
1	Diazepam (Valium)FDA LinkGeneric 11/2019
1	CannabinoidsIBA 11/2019
1	BilirubinIBA 05/2018
1	Alkaline PhosphataseIBA 05/2018
1	Dopamine (Intropin)FDA LinkGeneric 01/2018
1	SDMIBA 01/2018
1	Dopamine Agonists (Dopamine Agonist)IBA 01/2018
1	Levodopa (L Dopa)FDA LinkGeneric 01/2018
1	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 01/2018
1	Flumazenil (Romazicon)FDA LinkGeneric 10/2017
1	Psychotropic Drugs (Psychoactive Drugs)IBA 01/2017
1	SmokeIBA 01/2012
1	Cocaine (Cocaine HCl)IBA 08/2011
1	OF 743IBA 08/2011
1	Hepatitis A AntibodiesIBA 01/2011
1	NF-kappa B (NF-kB)IBA 12/2009
1	Venlafaxine Hydrochloride (Effexor)FDA LinkGeneric 09/2008
1	Antidepressive Agents (Antidepressants)IBA 10/2005
1	Tuberculin (PPD)IBA 01/2002

Therapy/Procedure

6	Opiate Substitution Treatment 01/2021 - 01/2012
5	Therapeutics 06/2022 - 08/2006
1	Secondary Prevention 01/2022
1	Transcranial Direct Current Stimulation 01/2020
1	Transcranial Magnetic Stimulation 01/2020
1	Subcutaneous Infusions 10/2017
1	Acupuncture Therapy 04/2003
1	Punctures 01/2002